Activation of Toll-like receptor 2 increases macrophage resistance to HIV-1 infection

Immunobiology

Volumn 218, Issue 12, 2013, Pages 1529-1536

  Victoria, Sabina ^a,b   Temerozo, Jairo R ^a   Gobbo, Livia ^a   Pimenta Inada, Haynna K ^a,c   Bou Habib, Dumith Chequer ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b INSTITUT PASTEUR DE MONTEVIDEO   (Uruguay)

^c INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

Chemokines; HIV; IL 10; Macrophages; Toll like receptor

Indexed keywords

BETA CHEMOKINE; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; INTERLEUKIN 10; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES; TOLL LIKE RECEPTOR 2; ZYMOSAN;

ANTIGEN FUNCTION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOREACTIVITY; IMMUNOSTIMULATION; INNATE IMMUNITY; MACROPHAGE FUNCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; UPREGULATION; VIRUS INHIBITION; VIRUS NEUTRALIZATION; VIRUS PARTICLE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS; HIV; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS TYPE-1; IL; IL-10; INTERLEUKIN; LIPOPOLYSACCHARIDE; LPS; MACROPHAGES; PAMP; PATHOGEN-ASSOCIATED MOLECULAR PATTERNS; PBMCS; PERIPHERAL BLOOD MONONUCLEAR CELLS; PHA; PHYTOHEMAGGLUTININ; TLR; TOLL-LIKE RECEPTOR; TOLL-LIKE RECEPTORS.; Β-CHEMOKINES;

ANTIGENS, CD4; ANTIVIRAL AGENTS; CELLS, CULTURED; CHEMOKINES; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-10; LIGANDS; LIPOPEPTIDES; MACROPHAGES; RECEPTORS, CCR5; TOLL-LIKE RECEPTOR 2; VIRUS REPLICATION; ZYMOSAN;

EID: 84885927651     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2013.06.006     Document Type: Article

References (38)

1. Ahmed N., Hayashi T., Hasegawa A., Furukawa H., Okamura N., Chida T., Masuda T., Kannagi M. Suppression of human immunodeficiency virus type 1 replication in macrophages by commensal bacteria preferentially stimulating Toll-like receptor 4. J. Gen. Virol. 2010, 91:2804.
2. Alfano M., Poli G. Role of cytokines and chemokines in the regulation of innate immunity and HIV. Mol. Immunol. 2005, 42:161.
3. Barbalat R., Lau L., Locksley R.M., Barton G.M. Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands. Nat. Immunol. 2009, 10:1200.
4. Berger E.A., Murphy P.M., Farber J.M. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 1999, 17:657.
5. Bol S.M., van Remmerden Y., Sietzema J.G., Kootstra N.A., Schuitemaker H., van't Wout A.B. Donor variation in in vitro HIV-1 susceptibility of monocyte-derived macrophages. Virology 2009, 390:205.
6. Brichacek B., Vanpouille C., Kiselyeva Y., Biancotto A., Merbah M., Hirsch I., Lisco A., Grivel J.C., Margolis L. Contrasting roles for TLR ligands in HIV-1 pathogenesis. PLoS One 2010, 5.
7. Brenchley J.M., Douek D.C. The mucosal barrier and immune activation in HIV pathogenesis. Curr Opin HIV AIDS 2008, 3:356.
8. Brenchley J.M., Price D.A., Schacker T.W., Asher T.E., Silvestri G., Rao S., Kazzaz Z., Bornstein E., Lambotte O., Altmann D., Blazar B.R., Rodriguez B., Teixeira-Johnson L., Landay A., Martin J.N., Hecht F.M., Picker L.J., Lederman M.M., Deeks S.G., Douek D.C. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 2006, 12:1365.
9. Brunette R.L., Young J.M., Whitley D.G., Brodsky I.E., Malik H.S., Stetson D.B. Extensive evolutionary and functional diversity among mammalian AIM2-like receptors. J. Exp. Med. 2012, 209:1969.
10. Buitendijk M., Eszterhas S.K., Howell A. Gardiquimod: a toll like receptor-7 agonist that inhibits HIV-1 infection of human macrophages and activated T cells. AIDS Res. Hum. Retroviruses 2013, 29:907.
11. Chavez-Sanchez L., Chavez-Rueda K., Legorreta-Haquet M.V., Zenteno E., Ledesma-Soto Y., Montoya-Diaz E., Tesoro-Cruz E., Madrid-Miller A., Blanco-Favela F. The activation of CD14, TLR4, and TLR2 by mmLDL induces IL-1beta, IL-6, and IL-10 secretion in human monocytes and macrophages. Lipids Health Dis. 2010, 9:117.
12. Chtarbanova S., Imler J.L. Microbial sensing by Toll receptors: a historical perspective. Arterioscler. Thromb. Vasc. Biol. 2011, 31:1734.
13. Cocchi F., DeVico A.L., Garzino-Demo A., Arya S.K., Gallo R.C., Lusso P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major. Science 1995, 270:1811.
14. Ding J., Rapista A., Teleshova N., Mosoyan G., Jarvis G.A., Klotman M.E., Chang T.L. Neisseria gonorrhoeae enhances HIV-1 infection of primary resting CD4+ T cells through TLR2 activation. J Immunol 2010, 184:2814.
15. Franchin G., Zybarth G., Dai W.W., Dubrovsky L., Reiling N., Schmidtmayerova H., Bukrinsky M., Sherry B. Lipopolysaccharide inhibits HIV-1 infection of monocyte- derived macrophages through direct and sustained down-regulation of CC chemokine receptor 5. J. Immunol. 2000, 164:2592.
16. Ghosh T.K., Mickelson D.J., Fink J., Solberg J.C., Inglefield J.R., Hook D., Gupta S.K., Gibson S., Alkan S.S. Toll-like receptor (TLR) 2-9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses. Cell. Immunol. 2006, 243:48.
17. Giorgi J.V., Hultin L.E., McKeating J.A., Johnson T.D., Owens B., Jacobson L.P., Shih R., Lewis J., Wiley D.J., Phair J.P., Wolinsky S.M., Detels R. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J. Infect. Dis. 1999, 179:859.
18. Heggelund L., Damas J.K., Yndestad A., Holm A.M., Muller F., Lien E., Espevik T., Aukrust P., Froland S.S. Stimulation of toll-like receptor 2 in mononuclear cells from HIV-infected patients induces chemokine responses: possible pathogenic consequences. Clin. Exp. Immunol. 2004, 138:116.
19. Jiang W., Lederman M.M., Hunt P., Sieg S.F., Haley K., Rodriguez B., Landay A., Martin J., Sinclair E., Asher A.I., Deeks S.G., Douek D.C., Brenchley J.M. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J. Infect. Dis. 2009, 199:1177.
20. Jin M.S., Lee J.O. Structures of the toll-like receptor family and its ligand complexes. Immunity 2008, 29:182.
21. Kawai T., Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011, 34:637.
22. Leulier F., Lemaitre B. Toll-like receptors - taking an evolutionary approach. Nat. Rev. Genet. 2008, 9:165.
23. Lima R.G., Van Weyenbergh J., Saraiva E.M., Barral-Netto M., Galvao-Castro B., Bou-Habib D.C. The replication of human immunodeficiency virus type 1 in macrophages is enhanced after phagocytosis of apoptotic cells. J. Infect. Dis. 2002, 185:1561.
24. Moanna A., Dunham R., Paiardini M., Silvestri G. CD4+ T-cell depletion in HIV infection: killed by friendly fire?. Curr. HIV/AIDS Rep. 2005, 2:16-20.
25. Montaner L.J., Griffin P., Gordon S. Interleukin-10 inhibits initial reverse transcription of human immunodeficiency. J. Gen. Virol. 1994, 75(Pt 12):3393.
26. Roy S., Dickerson R., Khanna S., Collard E., Gnyawali U., Gordillo G.M., Sen C.K. Particulate beta-glucan induces TNF-alpha production in wound macrophages via a redox-sensitive NF-kappabeta-dependent pathway. Wound Repair Regen. 2011, 19:411.
27. Saville M.W., Taga K., Foli A., Broder S., Tosato G., Yarchoan R. Interleukin-10 suppresses human immunodeficiency virus-1 replication in vitro in cells of the monocyte/macrophage lineage. Blood 1994, 83:3591.
28. Scudiero D.A., Shoemaker R.H., Paull K.D., Monks A., Tierney S., Nofziger T.H., Currens M.J., Seniff D., Boyd M.R. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 1988, 48:4827.
29. Souza T.M., Rodrigues D.Q., Passaes C.P., Barreto-de-Souza V., Aguiar R.S., Temerozo J.R., Morgado M.G., Fontes C.F., Araujo E.G., Bou-Habib D.C. The nerve growth factor reduces APOBEC3G synthesis and enhances HIV-1 transcription and replication in human primary macrophages. Blood 2011, 117:2944.
30. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805.
31. Thayil S.M., Ho Y.C., Bollinger R.C., Blankson J.N., Siliciano R.F., Karakousis P.C., Page K.R. Mycobacterium tuberculosis complex enhances susceptibility of CD4 T cells to HIV through a TLR2-mediated pathway. PLoS One 2012, 7(7):e41093.
32. Thibault S., Tardif M.R., Barat C., Tremblay M.J. TLR2 Signaling Renders Quiescent Naive and Memory CD4+ T Cells More Susceptible to Productive Infection with X4 and R5 HIV-Type 1. J Immunol 2007, 179:4357.
33. Thibault S., Fromentin R., Tardif M.R., Tremblay M.J. TLR2 and TLR4 triggering exerts contrasting effects with regard to HIV-1 infection of human dendritic cells and subsequent virus transfer to CD4+ T cells. Retrovirology 2009, 6:42.
34. Trapp S., Derby N.R., Singer R., Shaw A., Williams V.G., Turville S.G., Bess J.W., Lifson J.D., Robbiani M. Double-stranded RNA analog poly(I:C) inhibits human immunodeficiency virus amplification in dendritic cells via type I interferon-mediated activation of APOBEC3G. J. Virol. 2009, 83:884.
35. Trinchieri G., Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat. Rev. Immunol. 2007, 7:179.
36. Verani A., Scarlatti G., Comar M., Tresoldi E., Polo S., Giacca M., Lusso P., Siccardi A.G., Vercelli D. C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages. J. Exp. Med. 1997, 185:805.
37. Wang Y., Lehner T. Induction of innate immunity in control of mucosal transmission of HIV. Curr. Opin. HIV AIDS 2011, 6:398.
38. Zhou Y., Wang X., Liu M., Hu Q., Song L., Ye L., Zhou D., Ho W. A critical function of toll-like receptor-3 in the induction of anti-human immunodeficiency virus activities in macrophages. Immunology 2010, 131:40.